KENNETH KAISER: Open Payments
NPI 1073557039 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 77 payments from 21 companies in 2025. Trend: 2023 $2,400 · 2024 $1,734 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $249 |
| Axsome Therapeutics, Inc. | 13 | $190 |
| Corcept Therapeutics | 9 | $157 |
| Novo Nordisk Inc | 12 | $144 |
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Lilly USA, LLC | 3 | $49 |
| Astellas Pharma US Inc | 2 | $33 |
| Radius Health, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $25 |
Products named: Korlym, UBRELVY, Sunosi, Auvelity, QULIPTA, Rybelsus, XIFAXAN, LEQVIO.
Industry payments across MS — which companies pay providers there.
